Cargando…
Potential of Azadirachta indica as a Capping Agent for Antiviral Nanoparticles against SARS-CoV-2
A rare type of pneumonia later on referred to as COVID-19 was reported in China in December 2019. Investigations revealed that this disease is caused by a coronavirus previously identified as SARS-CoV-2, and since then, it has become a global pandemic with new strains emerging rapidly as a result of...
Autores principales: | Foka, Frank Eric Tatsing, Manamela, Nanabi, Mufamadi, Steven Maluta, Mufhandu, Hazel Tumelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499809/ https://www.ncbi.nlm.nih.gov/pubmed/36158879 http://dx.doi.org/10.1155/2022/5714035 |
Ejemplares similares
-
Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review
por: Foka, Frank Eric Tatsing, et al.
Publicado: (2023) -
Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2
por: Mufamadi, Maluta Steven, et al.
Publicado: (2023) -
Nanotechnology shows promise for next-generation vaccines in the fight against COVID-19
por: Mufamadi, Maluta Steven
Publicado: (2020) -
New triterpenoids from the kernels of Azadirachta indica
por: Wang, Hong-Wei, et al.
Publicado: (2013) -
Limonoid and Steroidal Saponin from Azadirachta indica
por: Liu, Lu, et al.
Publicado: (2014)